Repare Therapeutics Inc. Retained Earnings
Repare Therapeutics Inc. had Retained Earnings of -$461.33 million as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2025-11-14
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$461.33M.
- 2025-06-30: Retained Earnings (Accumulated Deficit) -$464.58M.
- 2025-03-31: Retained Earnings (Accumulated Deficit) -$447.84M.
- 2024-12-31: Retained Earnings (Accumulated Deficit) -$417.80M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2025-09-30 | -$461.33M 10-Q · filed 2025-11-14 |
| 2025-06-30 | -$464.58M 10-Q · filed 2025-08-08 |
| 2025-03-31 | -$447.84M 10-Q · filed 2025-05-13 |
| 2024-12-31 | -$417.80M 10-Q · filed 2025-11-14 |
| 2024-09-30 | -$389.13M 10-Q · filed 2024-11-07 |
| 2024-06-30 | -$354.72M 10-Q · filed 2024-08-06 |
| 2024-03-31 | -$319.95M 10-Q · filed 2024-05-07 |
| 2023-12-31 | -$333.11M 10-K · filed 2025-03-03 |
| 2023-09-30 | -$305.08M 10-Q · filed 2023-11-09 |
| 2023-06-30 | -$286.20M 10-Q · filed 2023-08-09 |
| 2023-03-31 | -$274.25M 10-Q · filed 2023-05-09 |
| 2022-12-31 | -$239.31M 10-K · filed 2024-02-28 |
| 2022-09-30 | -$207.66M 10-Q · filed 2022-11-09 |
| 2022-06-30 | -$283.12M 10-Q · filed 2022-08-04 |
| 2022-03-31 | -$245.02M 10-Q · filed 2022-05-05 |
| 2021-12-31 | -$210.27M 10-K · filed 2023-02-28 |
| 2021-09-30 | -$181.98M 10-Q · filed 2021-11-10 |
| 2021-06-30 | -$151.08M 10-Q · filed 2021-08-12 |
| 2021-03-31 | -$124.78M 10-Q · filed 2021-05-13 |
| 2020-12-31 | -$103.36M 10-K · filed 2022-03-01 |
| 2020-09-30 | -$88.09M 10-Q · filed 2020-11-12 |
| 2020-06-30 | -$74.34M 10-Q · filed 2020-08-13 |
| 2019-12-31 | -$49.94M 10-K · filed 2021-03-04 |